CervoMed Inc. Updates Investor Presentation Materials

On October 9, 2026, CervoMed Inc. filed a Current Report on Form 8-K under Item 7.01 (Regulation FD Disclosure). The company announced that updated information regarding its business operations, clinical studies, development plans, and financial position has been made available on the "Investors – Events and Presentations" section of its corporate website. CervoMed indicated that its representatives may use this presentation, in whole or in part, during upcoming conferences and meetings with investors and analysts. The filing serves as a notification of the availability of these materials and does not disclose specific new clinical trial results or financial data within the text of the 8-K itself. As per standard regulatory practice for Item 7.01 disclosures, the information provided is considered furnished and not "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into the company's other Securities Act filings unless specifically stated.